2013-02-28 12:38:16 - New Pharmaceuticals market report from GlobalData: "Healthcare, Regulatory and Reimbursement Landscape - Egypt"

GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Egypt". The report is an essential source of information and analysis on Egypt's healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

Egypt's population was 80 million in 2011 and is increasing due to a positive balance between the birth and death rate. Policymakers are now

presented with the problem of an increasing unemployment rate due to a lack of clear monetary policies. The pharmaceutical market was estimated at $2.6 billion in 2010 and is expected to reach approximately $5.3 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 7.2%. The medical devices market was estimated at approximately $766m in 2011 and is expected to reach $1 billion by 2020 at a CAGR of 3.8%. The positive trends in the Egyptian healthcare market can primarily be attributed to -


Full Report Details at
- www.fastmr.com/prod/544157_healthcare_regulatory_and_reimburseme ..


* Increasing access to healthcare facilities
* Proposed universal healthcare insurance
* Revising pricing policies for pharmaceuticals

Scope

The report provides information on Egypt's healthcare, regulatory and reimbursement landscape, and includes -

* Overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers
* Profiles and SWOT analysis of the major players in the pharmaceutical and medical devices market, namely GlaxoSmithKline (GSK), Sanofi, Novartis, Egyptian International Pharmaceutical Industries Company (EIPICO) and South Egypt Drug Industries Company (SEDICO). The major players covered for the medical devices market are F. Hoffmann-La Roche, Fresenius Medical Care, Gambro, B. Braun Melsungen and GSK.
* Insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs
* Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure
* Overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

* Develop business strategies by understanding the trends shaping and driving Egypt's healthcare market
* Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Egypt's healthcare market in the future
* Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance
* Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
* Identify, understand and capitalize on the opportunities and challenges in Egypt's healthcare market

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Report Guidance
3 Overview of the Pharmaceutical and Medical Device Market
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Supply Channels
3.1.3 Market Segments
3.1.4 Major Therapeutic Areas
3.1.5 Major Players
3.2 Medical Device Market
3.2.1 Market Overview
3.2.2 Overview of Top Five Segments
3.2.3 Major Players
3.3 Market Drivers and Barriers
3.3.1 Drivers
3.3.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare System
4.1.2 Reimbursement Process
4.1.3 Overview of Insurance Providers
4.1.4 Patient Share of Healthcare Spending
4.1.5 Drug Price Trends
4.1.6 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 Drug Approval Procedure for Pharmaceutical Products
4.2.3 New Medical Device Approval Process
4.2.4 Licensing Process for Pharmaceutical Manufacturing
4.2.5 Licensing Process for Pharmaceutical Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Pharmacy Regulations
4.2.10 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Analysis of the Current Political Environment
5.1.3 Healthcare Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserves
5.3.7 Trade Balance
5.3.8 Gross Fiscal Deficit
5.3.9 Gross Domestic Debt
5.3.10 Government Structural Balance
5.3.11 Major Industries
5.4 Demographics
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Facilities
5.5.2 Healthcare Parameters
5.5.3 Environmental Health
5.5.4 Healthcare Personnel
5.6 Healthcare Expenditure
5.6.1 Pharmaceutical Expenditure
5.6.2 Components of Healthcare Spending
5.6.3 Share of Public and Private Sectors
5.6.4 Spending in Pharmaceutical R&D

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=544157&dt=t

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.